241 related articles for article (PubMed ID: 23359154)
1. Development of a cytokine-modified allogeneic whole cell pancreatic cancer vaccine.
Laheru D; Biedrzycki B; Jaffee EM
Methods Mol Biol; 2013; 980():175-203. PubMed ID: 23359154
[TBL] [Abstract][Full Text] [Related]
2. Development of a cytokine-modified allogeneic whole cell pancreatic cancer vaccine.
Laheru D; Biedrzycki B; Thomas AM; Jaffee EM
Methods Mol Med; 2005; 103():299-327. PubMed ID: 15542914
[TBL] [Abstract][Full Text] [Related]
3. Immunologic approaches to the management of pancreatic cancer.
Laheru D; Biedrzycki B; Jaffee EM
Cancer J; 2001; 7(4):324-37. PubMed ID: 11561608
[TBL] [Abstract][Full Text] [Related]
4. A lethally irradiated allogeneic granulocyte-macrophage colony stimulating factor-secreting tumor vaccine for pancreatic adenocarcinoma. A Phase II trial of safety, efficacy, and immune activation.
Lutz E; Yeo CJ; Lillemoe KD; Biedrzycki B; Kobrin B; Herman J; Sugar E; Piantadosi S; Cameron JL; Solt S; Onners B; Tartakovsky I; Choi M; Sharma R; Illei PB; Hruban RH; Abrams RA; Le D; Jaffee E; Laheru D
Ann Surg; 2011 Feb; 253(2):328-35. PubMed ID: 21217520
[TBL] [Abstract][Full Text] [Related]
5. Algenpantucel-L immunotherapy in pancreatic adenocarcinoma.
Coveler AL; Rossi GR; Vahanian NN; Link C; Chiorean EG
Immunotherapy; 2016 Feb; 8(2):117-25. PubMed ID: 26787078
[TBL] [Abstract][Full Text] [Related]
6. Immunotherapy for pancreatic cancer: current concepts.
Kaufman HL; Di Vito J; Hörig H
Hematol Oncol Clin North Am; 2002 Feb; 16(1):159-97, viii. PubMed ID: 12063825
[TBL] [Abstract][Full Text] [Related]
7. Cytokine gene-modified cell-based cancer vaccines.
Reilly RT; Machiels JP; Emens LA; Jaffee EM
Methods Mol Med; 2002; 69():233-57. PubMed ID: 11987781
[No Abstract] [Full Text] [Related]
8. Anti-pancreatic tumor efficacy of a Listeria-based, Annexin A2-targeting immunotherapy in combination with anti-PD-1 antibodies.
Kim VM; Blair AB; Lauer P; Foley K; Che X; Soares K; Xia T; Muth ST; Kleponis J; Armstrong TD; Wolfgang CL; Jaffee EM; Brockstedt D; Zheng L
J Immunother Cancer; 2019 May; 7(1):132. PubMed ID: 31113479
[TBL] [Abstract][Full Text] [Related]
9. Gene therapy for pancreatic cancer.
Tseng JF; Mulligan RC
Surg Oncol Clin N Am; 2002 Jul; 11(3):537-69. PubMed ID: 12487056
[TBL] [Abstract][Full Text] [Related]
10. Vaccine therapy of established tumors in the absence of autoimmunity.
Hodge JW; Grosenbach DW; Aarts WM; Poole DJ; Schlom J
Clin Cancer Res; 2003 May; 9(5):1837-49. PubMed ID: 12738742
[TBL] [Abstract][Full Text] [Related]
11. The ubiquitin-like protein, ISG15, is a novel tumor-associated antigen for cancer immunotherapy.
Wood LM; Pan ZK; Seavey MM; Muthukumaran G; Paterson Y
Cancer Immunol Immunother; 2012 May; 61(5):689-700. PubMed ID: 22057675
[TBL] [Abstract][Full Text] [Related]
12. Epigenetically modified pancreatic carcinoma PANC-1 cells can act as cancer vaccine to enhance antitumor immune response in mice.
Tao Y; Lin F; Li T; Xie J; Shen C; Zhu Z
Oncol Res; 2013; 21(6):307-16. PubMed ID: 25198660
[TBL] [Abstract][Full Text] [Related]
13. Immunotherapeutic approaches in pancreatic cancer.
Stieler J
Recent Results Cancer Res; 2008; 177():165-77. PubMed ID: 18084958
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of cytokine gene transfection may differ for autologous and allogeneic tumour cell vaccines.
Todryk SM; Birchall LJ; Erlich R; Halanek N; Orleans-Lindsay JK; Dalgleish AG
Immunology; 2001 Feb; 102(2):190-8. PubMed ID: 11260324
[TBL] [Abstract][Full Text] [Related]
15. Pancreatic cancer: role of the immune system in cancer progression and vaccine-based immunotherapy.
Amedei A; Niccolai E; Prisco D
Hum Vaccin Immunother; 2014; 10(11):3354-68. PubMed ID: 25483688
[TBL] [Abstract][Full Text] [Related]
16. [Current topics and future to vaccine for pancreatic cancer].
Miyazawa M; Yamaue H
Nihon Jibiinkoka Gakkai Kaiho; 2013 May; 116(5):573-80. PubMed ID: 24024272
[No Abstract] [Full Text] [Related]
17. Autologous, allogeneic tumor cells or genetically engineered cells as cancer vaccine against melanoma.
Schadendorf D; Paschen A; Sun Y
Immunol Lett; 2000 Sep; 74(1):67-74. PubMed ID: 10996630
[TBL] [Abstract][Full Text] [Related]
18. Advances in therapeutic vaccines for pancreatic cancer.
Plate JM
Discov Med; 2012 Aug; 14(75):89-94. PubMed ID: 22935205
[TBL] [Abstract][Full Text] [Related]
19. Potential targets for pancreatic cancer immunotherapeutics.
Dodson LF; Hawkins WG; Goedegebuure P
Immunotherapy; 2011 Apr; 3(4):517-37. PubMed ID: 21463193
[TBL] [Abstract][Full Text] [Related]
20. Innovative treatments for pancreatic cancer.
Lieberman SM; Hörig H; Kaufman HL
Surg Clin North Am; 2001 Jun; 81(3):715-39. PubMed ID: 11459285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
